Silk Fiber-Reinforced Hyaluronic Acid-Based Hydrogel for Cartilage Tissue Engineering.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Mar 2021
Historique:
received: 27 02 2021
revised: 21 03 2021
accepted: 25 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 11 5 2021
Statut: epublish

Résumé

A continuing challenge in cartilage tissue engineering for cartilage regeneration is the creation of a suitable synthetic microenvironment for chondrocytes and tissue regeneration. The aim of this study was to develop a highly tunable hybrid scaffold based on a silk fibroin matrix (SM) and a hyaluronic acid (HA) hydrogel. Human articular chondrocytes were embedded in a porous 3-dimensional SM, before infiltration with tyramine modified HA hydrogel. Scaffolds were cultured in chondropermissive medium with and without TGF-β1. Cell viability and cell distribution were assessed using CellTiter-Blue assay and Live/Dead staining. Chondrogenic marker expression was detected using qPCR. Biosynthesis of matrix compounds was analyzed by dimethylmethylene blue assay and immuno-histology. Differences in biomaterial stiffness and stress relaxation were characterized using a one-step unconfined compression test. Cell morphology was investigated by scanning electron microscopy. Hybrid scaffold revealed superior chondro-inductive and biomechanical properties compared to sole SM. The presence of HA and TGF-β1 increased chondrogenic marker gene expression and matrix deposition. Hybrid scaffolds offer cytocompatible and highly tunable properties as cell-carrier systems, as well as favorable biomechanical properties.

Identifiants

pubmed: 33807323
pii: ijms22073635
doi: 10.3390/ijms22073635
pmc: PMC8036422
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Hydrogels 0
Silk 0
Hyaluronic Acid 9004-61-9
Fibroins 9007-76-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Christian-Albrechts-Universität zu Kiel
ID : F359958

Références

Acta Biomater. 2020 Jan 1;101:293-303
pubmed: 31726249
Acta Biomater. 2019 Jan 1;83:233-244
pubmed: 30366137
Adv Exp Med Biol. 2018;1077:371-387
pubmed: 30357699
J Tissue Eng. 2018 Oct 08;9:2041731418802438
pubmed: 30305887
Cell. 1978 Dec;15(4):1313-21
pubmed: 729001
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111701
pubmed: 33545860
Injury. 2008 Apr;39 Suppl 1:S77-87
pubmed: 18313475
Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:810-817
pubmed: 28482595
FEBS Lett. 2002 Sep 25;528(1-3):101-8
pubmed: 12297287
Carbohydr Polym. 2015 Jan 22;115:325-33
pubmed: 25439901
Biomaterials. 2010 Feb;31(4):631-40
pubmed: 19819543
J Funct Biomater. 2018 Jun 24;9(3):
pubmed: 29937524
Tissue Eng. 2004 Jul-Aug;10(7-8):1277-86
pubmed: 15363182
Knee. 2016 Jun;23(3):426-35
pubmed: 26947215
Appl Biochem Biotechnol. 2017 Aug;182(4):1548-1563
pubmed: 28138929
N Engl J Med. 1994 Oct 6;331(14):889-95
pubmed: 8078550
Biomaterials. 2011 Feb;32(4):1032-40
pubmed: 21074264
Cartilage. 2013 Jan;4(1):12-9
pubmed: 26069648
Cell. 1982 Aug;30(1):215-24
pubmed: 7127471
Am J Sports Med. 2020 Jan;48(1):210-221
pubmed: 31877102
Arthritis Rheum. 2005 Jul;52(7):2033-9
pubmed: 15986359
Biomaterials. 2016 Aug;98:1-22
pubmed: 27177218
Polymers (Basel). 2017 Dec 04;9(12):
pubmed: 30965974
J Inflamm (Lond). 2016 Sep 13;13(1):31
pubmed: 27625590
Tissue Eng Part A. 2017 Aug;23(15-16):859-872
pubmed: 28330431
Biomaterials. 2006 Sep;27(25):4434-42
pubmed: 16677707
Cartilage. 2010 Jan;1(1):29-42
pubmed: 26069534
Adv Funct Mater. 2014 Aug 6;24(29):4615-4624
pubmed: 25395921
Orthop J Sports Med. 2019 Jul 10;7(7):2325967119854442
pubmed: 31317047
Arch Biochem Biophys. 2000 Sep 15;381(2):205-12
pubmed: 11032407
Tissue Eng Part A. 2018 Oct;24(19-20):1481-1491
pubmed: 29681215
Nat Mater. 2017 Dec;16(12):1243-1251
pubmed: 28967913
Osteoarthritis Cartilage. 2007 May;15(5):479-86
pubmed: 17291789
Cartilage. 2012 Jul;3(3):205-21
pubmed: 26069634

Auteurs

Jan-Tobias Weitkamp (JT)

Department of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.
Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

Michael Wöltje (M)

Institute of Textile Machinery and High Performance Material Technology, 01069 Dresden, Germany.

Bastian Nußpickel (B)

Department of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.

Felix N Schmidt (FN)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, 22529 Hamburg, Germany.

Dilbar Aibibu (D)

Institute of Textile Machinery and High Performance Material Technology, 01069 Dresden, Germany.

Andreas Bayer (A)

Department of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.

David Eglin (D)

Mines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U 1059 Sainbiose, Centre CIS, F-42023 Saint-Etienne, France.

Angela R Armiento (AR)

AO Research Institute Davos, 7270 Davos Platz, Switzerland.

Philipp Arnold (P)

Department of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.
Institute of Functional and Clinical Anatomy, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.

Chokri Cherif (C)

Institute of Textile Machinery and High Performance Material Technology, 01069 Dresden, Germany.

Ralph Lucius (R)

Department of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.

Ralf Smeets (R)

Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, 20251 Ham-burg, Germany.

Bodo Kurz (B)

Department of Anatomy, Christian-Albrechts-University Kiel, 24118 Kiel, Germany.

Peter Behrendt (P)

Clinic for Orthopedic and Trauma Surgery, University Medical Center Schleswig-Holstein, Campus Kiel, 24015 Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH